Implementing Cancer Medicines on the WHO Model Lists of Essential Medicines Into National Systems

JAMA Oncology 2026

View at publisher
Authors: Kristina Jenei, Richard Sullivan
DOI: 10.1001/jamaoncol.2025.6339
Cited by: 2
References: 6

Abstract

This Viewpoint discusses national systems implementation of cancer medicines included in the WHO Model Lists of Essential Medicines.

Fields of Study & Subjects

Pharmaceutical Economics and Policy Health Systems Economic Evaluations Quality of Life Economic and Financial Impacts of Cancer

Publication details

Journal / source
JAMA Oncology
Publisher
American Medical Association (AMA)
Volume
12
Issue
5
Pages
443–443
Publication date
5 March 2026
Language
EN